| 2016-11-23 09:22:35|
JUNO 09:22 11/23 11/23/16
Juno Therapeutics plunges in pre-market
The stock was last down over 31.3% to $20.51, a new 52-week low and life low. At that price resistance is at the prior 52-week low at $22.37. There is no established support at current price, with shares possibly set to test to the $20 to $19 area on continued selling.